Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPCM
1226
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
| $6.43M | 0.01% |
+116,090
| New | +$5.89M |
|
1227
BancFirst
BANF
$3.73B
| $6.42M | 0.01% |
196,198
+99,670
| +103% | +$3.02M |
|
1228
8x8 Inc
EGHT
$280M
| $6.42M | 0.01% |
716,440
+608,371
| +563% | +$5.37M |
|
|
CGI
1229
DELISTED
Celadon Group Inc
CGI
| $6.42M | 0.01% |
310,310
+291,220
| +1,526% | +$7.17M |
|
|
KERX
1230
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $6.4M | 0.01% |
641,448
+425,646
| +197% | +$4.56M |
|
1231
Assembly Biosciences
ASMB
$733M
| $6.4M | 0.01% |
27,675
-5,808
| -17% | -$1.12M |
|
|
DD
1232
CALL
DELISTED
Du Pont De Nemours E I
DD
| $6.39M | 0.01% |
+105,300
| New | +$7.09M |
|
1233
Carter's
CRI
$1.25B
| $6.38M | 0.01% |
59,990
-374,706
| -86% | -$37.6M |
|
1234
Cognex
CGNX
$10.1B
| $6.38M | 0.01% |
+265,072
| New | +$6.51M |
|
1235
Liberty Media Series A
FWONA
$24.1B
| $6.37M | 0.01% |
262,840
+2,576
| +1% | +$66.5K |
|
1236
RB Global
RBA
$15.8B
| $6.37M | 0.01% |
+228,042
| New | +$6.26M |
|
1237
G-III Apparel Group
GIII
$1.4B
| $6.36M | 0.01% |
90,332
-54,410
| -38% | -$3.33M |
|
|
SIGM
1238
DELISTED
Sigma Designs Inc
SIGM
| $6.35M | 0.01% |
532,535
+16,444
| +3% | +$151K |
|
1239
CALL
Carlyle Group
CG
$17.4B
| $6.33M | 0.01% |
+225,000
| New | +$6.59M |
|
|
INN
1240
Summit Hotel Properties
INN
$669M
| $6.33M | 0.01% |
486,227
-205,647
| -30% | -$2.74M |
|
1241
Wendy's
WEN
$1.73B
| $6.32M | 0.01% |
560,227
-386,122
| -41% | -$4.25M |
|
1242
Repligen
RGEN
$10.3B
| $6.32M | 0.01% |
153,056
+120,263
| +367% | +$4.41M |
|
1243
Gerdau
GGB
$8.5B
| $6.32M | 0.01% |
3,301,665
-318,209
| -9% | -$767K |
|
1244
Navios Maritime Partners
NMM
$2.59B
| $6.31M | 0.01% |
39,327
-2,856
| -7% | -$498K |
|
1245
Autohome
ATHM
$2.51B
| $6.29M | 0.01% |
124,462
-34,492
| -22% | -$1.7M |
|
1246
Avis
CAR
$5.14B
| $6.28M | 0.01% |
142,542
-67,417
| -32% | -$3.56M |
|
|
FCS
1247
DELISTED
FAIRCHILD SEMICONDUCTOR INTL INC COMMON
FCS
| $6.28M | 0.01% |
361,256
-1,304,922
| -78% | -$25M |
|
1248
United Natural Foods
UNFI
$2.87B
| $6.26M | 0.01% |
98,380
+29,765
| +43% | +$2.02M |
|
1249
CALL
PBF Energy
PBF
$8.03B
| $6.26M | 0.01% |
+220,400
| New | +$6.2M |
|
1250
CALL
Qualcomm
QCOM
$168B
| $6.26M | 0.01% |
100,000
+89,800
| +880% | +$6.13M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.